Skip to content

Stepped Care for depression and anxiety in younger adults with visual impairment: implementation study

Stepped Care for depression and anxiety in younger adults with visual impairment: implementation study - Stepped Care 18+ implementation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56858
Enrollment
82
Registered
2024-06-17
Start date
2024-07-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression in people with eye diseases

Interventions

The intervention has a step-by-step character (stepped care), with an increasing intensity. The intervention consists of the following steps: 1) period of vigilance (including psycho-education), 2)

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Usability: People with visual impairment (visual acuity of max. 0.5 snellen) Proeftuin: People with visual impairment, who have subclinical symptoms of depression/anxiety Interviews: stakeholders/professionals who can have an impact on the positive implementation of stepped care in the organisaitons.

Exclusion criteria

Exclusion criteria: Usability: not being able to use the computer. Proeftuin: having a psychiatric disorder and being cognitively impaired. Interviews: -

Design outcomes

Primary

MeasureTime frame
The developed online modules in Minddistrict will be tested in a usability study, after which the intervention can be adjusted/improved. Subsequently, the intervention will be put into practice by means of a 1.5-year testing period. During the testing period, it will be tested whether the intervention has an effect on complaints of depression and anxiety. Quality of life will also be measured before and after following the intervention. In addition, interviews will be conducted with stakeholders within the organizations where the intervention will be implemented (Royal Dutch Visio, Robert Coppes Foundation and Amsterdam UMC ophthalmology department). From this follows an implementation plan.

Secondary

MeasureTime frame
N/a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026